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Prevalence and Antimicrobial Agent 
Susceptibility of Methicillin-resistant 
Staphylococcus aureus in Healthy Pediatric 
Outpatients in Las Vegas 
 
Echezona E. Ezeanolue, M.D.,  
Mark P. Buttner, Ph.D., Patricia Cruz, Ph.D., 
Joanne L. Henry, B.S., Chad L. Cross, Ph.D., 
Linda D. Stetzenbach, Ph.D. 
Abstract 
 Colonization and infection by community-
associated resistant strains of Staphylococcus aureus 
are being reported in epidemic proportions.  The 
purpose of this study was to determine the local 
prevalence of methicillin-resistant Staphylococcus 
aureus (MRSA) colonization in children and to 
characterize the MRSA isolates in the laboratory with 
regard to antimicrobial agent susceptibility patterns, 
and the presence of the mecA and the Panton-
Valentine leukocidin (PVL) genes.  Nasal swabs 
were collected at two pediatric clinics from a total of 
505 children during health maintenance visits.  A 
brief questionnaire was administered to collect 
demographic data and pertinent medical, family, and 
social history.  Samples were cultured onto 2 
selective media for S. aureus and MRSA.  Potential 
MRSA isolates were further evaluated by real-time 
polymerase chain reaction (PCR), and for 
susceptibility to eight antibiotics by disk diffusion.  
Culture results showed that MRSA was present in 15 
of the 505 specimens (3.0%).  Six different 
antimicrobial susceptibility profiles were observed 
among the MRSA isolates.  PCR amplification 
results showed that all 15 MRSA isolates were 
positive for the presence of the mecA gene, and 10 
MRSA isolates contained the PVL gene.  
Understanding local prevalence rates and the role of 
colonization in infection are needed to develop 
effective interventions to reduce MRSA infections 
Key words: community-associated MRSA, 
methicillin-resistant Staphylococcus aureus, nasal 
carriage, pediatric 
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Colonization and infection by community-associated 
resistant strains of Staphylococcus aureus are being 
reported in epidemic proportions in many areas of the 
United States and around the world (Creech II, 
Kernodle, Alsentzer, Wilson, & Edwards, 2005).  
Although more frequently associated with skin and 
soft tissue infections, community-associated 
methicillin-resistant Staphylococcus aureus (CA-
MRSA) has been implicated in invasive infections in 
children, with wide geographical diversity in rates of 
colonization and infection (Hussain, Boyle-Vavra, & 
Daum, 2001; Kaplan et al., 2005; Kuehnert et al., 
2005). 
 The increasing rate of MRSA infections has led 
many clinicians to utilize newer staphylococcal 
antimicrobial agents such as linezolid, as first line 
empiric therapy.  While some studies report equal 
efficacy or superiority of linezolid to vancomycin in 
treatment of MRSA (Sharpe, Shively, & Polk Jr., 
2005; Shorr, Kunkel, & Kollef, 2005), there are 
reports of increasing clindamycin and rifampin 
resistance among methicillin-resistant 
Staphylococcus aureus and of unstable vancomycin 
heteroresistance among clinical isolates of MRSA 
(Plipat, Livni, Bertram, & Thompson, 2005; Tosun et 
al., 2005).  The two most important considerations in 
choosing empiric antibiotic therapy are the  
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knowledge of the most likely pathogen and the most 
likely active agent.  With the increasing prevalence of 
MRSA, the large geographical diversity in 
colonization and infection rates, and the presence of 
increasing resistance to available therapies, clinicians 
should be aware of their local resistance rates. 
 One method of gaining this knowledge is to 
maintain inpatient and outpatient surveillance 
programs, and to identify local colonization rates and 
their relationship to clinical infections as well as 
antimicrobial resistance patterns.  The anterior nares 
are the primary reservoir of Staphylococcus aureus in 
adults and children (Casewell, 1998; Kluytmans, van 
Belkum, & Verbrugh, 1997) with approximately one-
third of the general population colonized at any given 
time (Kluytmans, van Belkum, & Verbrugh, 1997).  
Nasal carriage is a significant risk factor for 
staphylococcal infection (Davis, Stewart, Crouch, 
Florez, & Hospenthal, 2004; Kluytmans, van 
Belkum, & Verbrugh, 1997), with >80% of infecting 
isolates originating from the nose (vonEiff, Becker, 
Machka, Stammer, & Peters, 2001; Wertheim et al., 
2004).  In addition, eradication of nasal carriage often 
eliminates the organism from other body sites (Parras 
et al., 1995; Reagan et al., 1991). 
 The purpose of this study was to determine the 
local prevalence of MRSA nasal colonization in 
children.  Isolates were also characterized with regard 
to:  1) the presence of the mecA gene, encoding the 
altered penicillin binding protein responsible for 
[beta]-lactam resistance; 2) antimicrobial 
susceptibility patterns; and 3) the presence of a 
specific virulence factor gene, Panton-Valentine 
leukocidin (PVL) (Baggett et al., 2004; Deurenberg 
et al., 2004; Hsu et al., 2004).  This information will 
help in the development of recommendations for 
selecting antimicrobial therapy, and is the first step in 
maintaining a comprehensive pediatric database of 
the antimicrobial susceptibility of infection-causing 
microorganisms for Las Vegas, Nevada hospitals. 
Materials and Methods 
Study Design 
 The purpose of this study was to determine the 
prevalence of MRSA in healthy children aged 2 
weeks to 21 years.  Age ranges in this study are 
defined as infants (birth–2 years), adolescents (12–17 
years), and young adults (18–21 years).  Nasal swabs 
were collected from 505 children during health 
maintenance visits at two sites, Kids Health Pediatric 
Clinic and Lied Clinic of the University Medical 
Center in Las Vegas, Nevada.  A brief questionnaire 
was administered by the pediatric staff to each child 
or responsible adult to collect demographic data and 
pertinent medical, family and social history.  
Specimens were cultured onto two selective media 
for the isolation of S. aureus and MRSA.  Swabs 
were then enriched and subcultured onto selective 
media after 24 hours of incubation.  Real-time 
polymerase chain reaction (PCR) was used to analyze 
MRSA isolates for the presence of mecA and PVL 
genes.  The Kirby-Bauer disk diffusion method was 
used to further characterize isolates based on their 
susceptibility to eight antimicrobial agents.  Data 
were analyzed statistically to determine MRSA 
prevalence rates and geospatial representation of 
MRSA-positivity in Clark County. 
Test Organisms and Culture Media 
 Four bacterial reference strains were used in this 
study, including Escherichia coli ATCC 25922, S.  
aureus ATCC 25923 (a methicillin-sensitive strain), 
S. aureus ATCC 43300 (a MRSA strain), and S. 
epidermidis ATCC 12228  (American Type Culture 
Collection, Manassas, VA).  All media were obtained 
from BD Diagnostics, Sparks, MD, and included 
BBL™ CHROMagar™ Staph aureus, BBL™ 
CHROMagar™ MRSA, Mueller Hinton II agar, 
Difco™ tryptic soy agar, Trypticase™ soy agar with 
5% sheep blood, and Trypticase™ soy broth with 
6.5% sodium chloride (enrichment broth).  All 
cultures were incubated at 35°C for 24–48 hours. 
Specimen Collection and Processing 
 Collection techniques and laboratory methods 
were modeled after the previous work of Nakamura 
(Nakamura et al., 2002).  Specimens were collected 
by pediatric staff with a dry, sterile swab (BBL 
CultureSwab; BD Diagnostics) which was inserted 
into each nostril of each subject, rotated for 5 
seconds, and placed into a tube of liquid Stuart 
transport medium (BD Diagnostics).  Specimens 
were refrigerated overnight, transported to the 
laboratory the following morning, and processed 
immediately upon arrival.  Swabs were streaked for 
isolation onto CHROMagar™ Staph aureus and 
CHROMagar™ MRSA, placed in enrichment broth, 
then vortexed for 10 seconds.  All agar plate media 
were incubated at 35°C for 24 hours.  The enrichment 
broth cultures were shaken at 130 rpm for 24 hours in 
a 35°C environmental shaker incubator.  The results 
were recorded and CHROMagar™ MRSA plates 
without typical MRSA colonies were incubated for 
an additional 24 hours.  The enrichment broth was 
subcultured onto CHROMagar™ Staph aureus and 
CHROMagar™ MRSA and streaked for isolation; 
plates were incubated at 35°C for 24 hours.  After 
recording the results, the negative CHROMagar™ 
MRSA plates were incubated for another 24 hours.  
Media performance characteristics were obtained 
from the manufacturer’s package inserts.  Mauve to 
orange/mauve colonies produced on CHROMagar™ 
Staph aureus medium were identified as S. aureus 
isolates.  Smooth, moderately sized mauve colonies 
which appeared on CHROMagar™ MRSA medium 
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at 24 hours were interpreted as MRSA isolates.  
Mauve colonies appearing at 48 hours and those with 
atypical growth rates or colony morphology were 
confirmed with further testing.  These isolates were 
subcultured to Trypticase™ soy agar with 5% sheep 
blood, incubated for 24 hours, and then tested for 
coagulase activity (ASI Staphslide Latex Test; 
Arlington Scientific, Inc., Springville, UT) according 
to the manufacturer’s instructions.  All presumptive 
MRSA isolates were Gram stained and then stored at 
–70°C for use in additional testing. 
Antimicrobial Susceptibility Testing 
 Antimicrobial susceptibility testing was 
performed by Kirby-Bauer disk diffusion (direct 
method) on Mueller Hinton medium according to 
Clinical and Laboratory Standards Institute (Wayne, 
PA) standards and included the following 
antimicrobial agents:  clindamycin (2 μg), 
erythromycin (15 μg), gentamicin (10 μg), linezolid 
(30 μg), mupirocin (5 μg), rifampin (5 μg), 
trimethoprim-sulfamethoxazole (1.25 μg/23.75 μg), 
and vancomycin (30 μg).  All antimicrobial agents 
were obtained from Becton Dickinson, except 
mupirocin, which was obtained from Mast 
Diagnostics, Merseyside, UK.  Organisms included in 
testing for quality control purposes were S. aureus 
ATCC 25923 and E. coli ATCC 25922.  Presumptive 
MRSA isolates were subcultured onto tryptic soy 
agar and incubated for 24 hours.  Each bacterial 
suspension was prepared according to the 
antimicrobial agents manufacturers’ instructions by 
inoculating 5 ml of Bacto™ tryptic soy broth (BD 
Diagnostics) with a few isolated colonies and diluting 
the suspension as needed to obtain turbidity 
equivalent to a 0.5 McFarland standard (Wanger, 
2007).  Within 15 minutes of preparation, a sterile 
cotton swab was dipped into the suspension; excess 
liquid was expressed from the swab.  The agar 
surface was inoculated three times, rotating the plate 
60° each time, then sweeping the swab around the 
outer rim of the agar.  The plates were allowed to dry 
for 3–5 minutes before applying the disks.  Four 
disks were placed manually onto each plate with 
sterile forceps and pressed firmly onto the surface.  
To detect inducible clindamycin resistance, double 
disk diffusion testing (D test) was performed by 
placing the clindamycin and erythromycin disks 15 
mm apart (center to center); all other disks were 
placed 30 mm apart (Fiebelkorn, Crawford, 
McElmeel, & Jorgensen, 2003; Frank et al., 2002).  
Plates were incubated aerobically at 35°C for 16–18 
hours.  Zone diameters were measured to the nearest 
millimeter and results were recorded as susceptible, 
intermediate, or resistant based on interpretive 
criteria provided by the antimicrobial agents 
manufacturers. 
DNA Extraction and Purification 
 Several colonies from each MRSA isolate were 
suspended in 0.5 ml 0.01 M potassium phosphate 
buffer with 0.05% Tween 20 (Sigma-Aldrich Co., St. 
Louis, MO) (pH 7.0).  DNA extraction and 
purification from all test and control cultures were 
performed using previously published protocols 
(Buttner et al., 2004).  Briefly, each suspension was 
pretreated with sodium dodecyl sulfate and 
proteinase K, incubated at 50°C, then boiled and 
chilled on ice.  Bovine serum albumin was added, 
followed by incubation at 37°C in a rotary shaker.  
The DNA from all isolates was purified by using the 
Pellet Paint protocol (Novagen, Madison, WI).  
Pellets were air dried overnight, then resuspended in 
50 μl of Tris-EDTA buffer (pH 8.0) and stored at –
70°C. 
Polymerase Chain Reaction 
 A real-time PCR assay utilizing the TaqMan® 
(Applied Biosystems, Foster City, CA) technology 
was used to detect the mecA gene (Francois et al., 
2003).  The 7900 HT Fast Real-Time PCR System 
(Applied Biosystems) was used for PCR analysis.  
All primers were obtained from Operon Technologies 
(Huntsville, AL) and the probes were obtained from 
Applied Biosystems.  Presumptive isolates were 
analyzed using the oligonucleotide primers and probe 
specified previously (Francois et al., 2003).  The 
mecA primer sequences (5  to 3 ) were as follows: 
cattgatcgcaacgttcaattt (forward) and 
tggtctttctgcattcctgga (reverse).  The TaqMan® probe 
sequence was 6-FAM-tggaagttagattgggatcatagcgtcat-
TAMRA.  The reaction conditions included:  5 μl 
genomic DNA, 1X TaqMan® Universal PCR Master 
Mix (Applied Biosystems), 100 nM of each primer, 
and 75 nM of probe.  The reaction volume was 
adjusted to 25 μl with nuclease-free water (Promega 
Corp., Madison, WI).  The TaqMan® amplification 
conditions in Standard mode were 2 min at 50°C, 10 
min at 95°C, and 40 cycles of 15 sec at 95°C 
followed by 1 min at 60°C.  Isolates were further 
analyzed for the PVL gene by real-time PCR with the 
use of oligonucleotide primers and probe sequences 
as described previously (Deurenberg et al., 2004).  
The PVL primer sequences (5  to 3 ) were: 
gctggacaaaacttcttggaatat (forward) and 
gataggacaccaataaattctggattg (reverse).  The 
TaqMan® probe sequence was 6-FAM-
aaaatgccagtgttatcca-MGBNFQ.  The reaction 
conditions included 5 μl genomic DNA, 1X 
TaqMan® Universal PCR Master Mix, 0.6 μM of 
each primer, and 175 nM MGB probe.  The reaction 
volume was adjusted to 25 μl with nuclease-free 
water.  The amplification conditions were as 
described above.  All MRSA isolates were amplified 
in duplicate, and negative and positive controls were 
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included with each PCR assay.  DNA for both mecA 
and PVL genes was assayed both undiluted and 
diluted 10-fold.  In addition, a 100-fold dilution was 
assayed for the PVL gene.  After amplification, the 
data were analyzed and plotted (fluorescence vs. 
cycle number) using the software provided with the 
7900 PCR System.  The extent of amplification was 
reported by the software as the mean CT value of two 
replicates.  CT refers to the PCR cycle number where 
detectable amplification product is measured, and is 
inversely proportional to the initial DNA template 
concentration. 
Statistical Methods and Analyses 
 The number of study participants was 
determined based on the population of 20,000 
patients between the ages of 2 and 21 years that 
utilize the two clinics (14,000 at the Lied Clinic of 
the University Medical Center, and 6,000 at the Kids 
Health Pediatric Clinic).  An estimated MRSA 
colonization rate of 2.4% (a three fold increase from 
the average national rate of 0.8%) and a 
hypergeometric distribution (sampling without 
replacement – i.e., patients sampled only once 
throughout the study) were utilized.  This resulted in 
an estimate that 475 participants were needed to 
provide a population MRSA colonization prevalence 
rate with 95% confidence and a power of 0.80 (alpha 
= 0.05; Fisher exact test method).  Descriptive and 
inferential statistics were calculated for all variables 
using SPSS version 15.0, SAS version 9.1, and 
NCSS/PASS 2004. 
Results 
Culture Analysis 
 A total of 505 nasal swabs were obtained from 
the two pediatric clinics.  Results of culture analysis 
showed that 15 of the 505 specimens (3.0%) were 
positive for the presence of MRSA.  Ten positive 
specimens were obtained from the Kids Health 
Pediatric Clinic and five positive specimens were 
obtained from the Lied Clinic of the University 
Medical Center.  Of the MRSA positive specimens, 5 
were obtained 24 hours after direct inoculation onto 
CHROMagar
TM
 MRSA, 1 was obtained 48 hours 
after direct inoculation, and 9 were obtained after 
enrichment for 24 hours.  Incubation of the plated 
enrichment broth for 48 hours yielded no additional 
positive results.  Although mauve colonies appeared 
on 13 of the enriched specimens at 48 hours, these 
were ruled out as potential MRSA by negative 
coagulase tests. 
 S. aureus was isolated with CHROMagar
TM
 
Staph aureus in a total of 177 of 505 specimens 
(35.0%).  The prevalence of MRSA among S. aureus 
isolates was 8.5%.  Of the positive S. aureus 
specimens, 115 were obtained by direct inoculation 
and 62 were detected only after enrichment.  For 2 
specimens in which positive results were obtained by 
direct inoculation (1 and 2 CFU, respectively), 
enrichment results were negative.  All positive 
MRSA specimens obtained with CHROMagar
TM
 
MRSA were also positive for S. aureus on 
CHROMagar
TM
 Staph aureus. 
Questionnaire Data 
 A total of 498 questionnaires were obtained with 
the 505 specimens.  All positive MRSA specimens 
were accompanied by completed questionnaires.  The 
number of respondents between categories varied due 
to incomplete or missing information obtained for 
some questions.  Basic summary statistics from the 
questionnaire responses from patients showed a 
median age of 4.9 and 1.9 years of age for Kids 
Health Pediatric Clinic (N = 230) and Lied Clinic (N 
= 251), respectively.  Combined demographics for 
both clinics showed that 4.3% (21/488) of the 
participants had lived in a group home in the past 
year, 5.0% (25/498) had a household member 
working in a hospital or clinic, and 1.2% (6/498) had 
a household member working in a correctional 
facility.  The medical history of the participants from 
both clinics revealed that 68 of 490 (13.9%) had a 
history of chronic illness, 86 of 488 (17.6%) had been 
hospitalized, and 24 of 408 (5.9%) had been admitted 
to the intensive care unit of a hospital.  The antibiotic 
use history of the participants indicated that 219 of 
478 (45.8%) had been treated with antibiotics, 136 of 
409 (33.3%) in the past year, and 42 of 405 (10.4%) 
in the last month.  Questionnaire responses from 
adolescents and young adults (ages 12–21), revealed 
that 1 in 65 (1.5%) had used intravenous illegal drugs 
or done skin popping, 3 in 66 (4.5%) had tattoos, and 
2 in 60 (3.3%) had been in jail or juvenile detention. 
 Analysis of the questionnaire data from families 
with children colonized by MRSA showed a median 
age of 3.2 and 0.6 years of age for Kids Health 
Pediatric Clinic and Lied Clinic, respectively (Table 
1).  Combined demographics for both clinics showed 
that of 15 patients, one had lived in a group home in 
the past year, 3 had a household member working in 
a hospital or clinic, and 1 had a household member 
working in a correctional facility (Table 1).   
 
Table 1.  Demographics of MRSA positive patients 
seen at Kids Health Pediatric Clinic and Lied Clinic, 
Las Vegas, NV as reported on the study questionnaire 
by each child or responsible adult (S.D. = standard 
deviation). 
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Variable Clinic N Mean SD Median Minimum Maximum 
Age 
(yrs) 
Kids 
Health 
9 5.0 5.56 3.2 0.5 15.4 
Lied 
Clinic 
5 4.6 7.09 0.6 0.3 16.8 
Total 
People 
in Home 
Kids 
Health 
9 5.4 2.24 5.0 2.0 9.0 
Lied 
Clinic 
5 5.8 1.92 6.0 3.0 8.0 
 
Variable Category 
Kids Health (N = 10) Lied Clinic (N = 5) 
Frequency Percent Frequency Percent 
Gender 
Female 2 20.0 3 60.0 
Male 8 80.0 2 40.0 
City 
North Las 
Vegas 
3 30.0 1 20.0 
Henderson 1 10.0 0   0.0 
Las Vegas 6 60.0 4 80.0 
School 
Daycare 1 10.0 1 20.0 
Elementary 1 10.0 0   0.0 
Middle/High 2 20.0 1 20.0 
None 6 60.0 3 60.0 
      
Question 
Kids Health Lied Clinic 
N No Yes N No Yes 
Has participant lived in 
group home in past year? 
10 
10 
(100%) 
0(0%) 5 
4 
(80%) 
1 
(20%) 
Does any member of the 
participant’s household 
work in a hospital/clinic? 
10 
7  
(70%) 
3 
(30%) 
5 
5 
(100%) 
0  
(0%) 
Does any member of the 
participant’s household 
work in a chronic care 
facility? 
10 
10 
(100%) 
0 
(0%) 
5 
5 
(100%) 
0  
(0%) 
Does any member of the 
participant’s household 
work in a school? 
10 
7  
(70%) 
3 
(30%) 
5 
4 
(80%) 
1 
(20%) 
Does any member of the 
participant’s household 
work in a daycare? 
10 
10 
(100%) 
0 
(0%) 
5 
5 
(100%) 
0  
(0%) 
Does any member of the 
participant’s household 
work in a correctional 
facility? 
10 
10 
(100%) 
0 
(0%) 
5 
4 
(80%) 
1 
(20%) 
Does any member of the 
participant’s household 
work in a home/school for 
disabled persons? 
10 
10 
(100%) 
0 
(0%) 
5 
5 
(100%) 
0  
(0%) 
The medical history indicated that 5 of the 15 
children had been hospitalized (Table 2).  The 
antibiotic use history of these children indicated that 
10 of 15 (66.7%) had been treated with antibiotics, 9 
of 13 (69.2%) in the past year, and 4 of 12 (33.3%) in 
the last month (Table 3).  Questionnaire responses 
from MRSA positive adolescents and young adults 
(N = 4) revealed that one had used intravenous illegal 
drugs or done skin popping, and had been in jail or 
juvenile detention (Table 4). 
 
Table 2.  Medical history of MRSA positive patients 
seen at Kids Health Pediatric Clinic and Lied Clinic, 
Las Vegas, NV as reported on the study questionnaire 
by each child or responsible adult (NICU = neonatal 
intensive care unit). 
Question 
Kids Health Lied Clinic 
N No Yes N No Yes 
Does the participant 
have a history of 
chronic illness? 
10 
9  
(90%) 
1  
(10%) 
5 
4  
(80%) 
1  
(20%) 
Has the participant 
been hospitalized? 
10 
7  
(70%) 
3  
(30%) 
5 
3  
(60%) 
2  
(40%) 
Does any member 
of the participant’s 
household have a 
history of chronic 
illness? 
10 
9  
(90%) 
1  
(10%) 
5 
4  
(80%) 
1  
(20%) 
If an infant, did s/he 
spend a prolonged 
time in a nursery or 
NICU? 
2 
2  
(100%) 
0  
(0%) 
1 
1  
(100%) 
0  
(0%) 
Table 3.  Antibiotic use history of MRSA positive 
patients seen at Kids Health Pediatric Clinic and Lied 
Clinic, Las Vegas, NV as reported on the study 
questionnaire by each child or responsible adult. 
 
Table 4.  MRSA positive adolescent and young adult 
(12–21 year-old) basic summary statistics from Kids 
Health Pediatric Clinic and Lied Clinic, Las Vegas, 
NV as reported on the study questionnaire by each 
child or responsible adult (IV = intravenous). 
      
 
 
 
Question Kids Health Lied Clinic 
 N No Yes N No Yes 
Has the participant 
ever been treated 
with antibiotics? 
10 
3  
(30%) 
7  
(70%) 
5 
2  
(40%) 
3  
(60%) 
Has the participant 
been treated with 
antibiotics in the past 
year? 
9 
3  
(33%) 
6  
(67%) 
4 
1  
(25%) 
3  
(75%) 
Has the participant 
been treated with 
antibiotics in the last 
month? 
8 
5  
(62%) 
3  
(38%) 
4 
3  
(75%) 
1  
(25%) 
Has any member of 
the participant’s 
household used 
antibiotics? 
0 
0  
(0%) 
0  
(0%) 
0 
0  
(0%) 
0  
(0%) 
Has any member of 
the participant’s 
household been 
treated with 
antibiotics in the past 
year? 
9 
3  
(33%) 
6  
(67%) 
4 
2  
(50%) 
2  
(50%) 
Has any member of 
the participant’s 
household been 
treated with 
antibiotics in the last 
month? 
9 
5  
(56%) 
4  
(44%) 
5 
5  
(100%) 
0  
(0%) 
Question 
Kids Health Lied Clinic 
N No Yes N No Yes 
Do you smoke 
cigarettes? 
3 
3  
(100%) 
0  
(0%) 
1 
1  
(100%) 
0  
(0%) 
Have you ever used 
IV illegal drugs or 
done skin popping? 
3 
3  
(100%) 
0  
(0%) 
1 
0  
(0%) 
1  
(100%) 
Do you have 
tattoos? 
3 
3  
(100%) 
0  
(0%) 
1 
1  
(100%) 
0  
(0%) 
Do you have pierced 
ears? 
3 
1  
(33%) 
2  
(67%) 
1 
1  
(100%) 
0  
(0%) 
Do you have 
piercings in any 
other parts of your 
body? 
2 
2  
(100%) 
0  
(0%) 
1 
1  
(100%) 
0  
(0%) 
Do you work? 3 
3  
(100%) 
0  
(0%) 
1 
1  
(100%) 
0  
(0%) 
Do you have a 
boyfriend/girlfriend? 
3 
3  
(100%) 
0  
(0%) 
1 
1  
(100%) 
0  
(0%) 
Have you ever been 
in juvenile detention 
or jail? 
1 
1  
(100%) 
0  
(0%) 
1 
0  
(0%) 
1  
(100%) 
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Antimicrobial Susceptibility Testing 
 Six different antimicrobial agent susceptibility 
profiles were observed from the MRSA isolates 
(Table 5).  Four of the isolates were susceptible to all 
eight antimicrobial agents tested.  Conversely, one 
isolate was resistant to four antimicrobial agents.  
Resistance to erythromycin was most frequent, 
followed by clindamycin resistance.  Inducible 
clindamycin resistance due to erythromycin was 
observed for two isolates. 
 
Table 5.  Antimicrobial agent susceptibility results 
obtained for MRSA positive specimens.  E. coli 
ATCC 25922 and S. aureus ATCC 25923 were used 
as QC organisms.  Antimicrobial agent susceptibility 
[susceptible (S), intermediate (I), and resistant (R)] 
was determined with the Zone Diameter for 
Staphylococcus spp. Interpretive Standards (CC = 
Clindamycin, 2 μg; E = Erythromycin, 15 μg; GM = 
Gentamicin, 10 μg; LZD = Linezolid, 30 μg; RA = 
Rifampin, 5 μg; SXT = Trimethoprim/ 
Sulfamethoxazole, 1.25 μg/23.75 μg; Va = 
Vancomycin, 30 μg; MUP = Mupirocin, 5 μg). 
 
a D-zone effect observed between clindamycin and erythromycin 
 
Polymerase Chain Reaction Analysis 
 PCR results are summarized in Table 6.  All 
MRSA isolates were confirmed by positive 
amplification results for the presence of the mecA 
gene.  Ten of the fifteen MRSA isolates contained the 
PVL gene, including all five isolates obtained from 
children who had been hospitalized.  Dilutions of the 
DNA were performed for all samples, and sometimes 
produced a stronger amplification result (lower cycle 
threshold value, CT), indicating that partial PCR 
inhibition occurred due to high concentrations of 
DNA in the specimen (data not shown). 
 
Table 6.  PCR results obtained for the amplification 
of MRSA isolates.  Targets consisted of the PVL and 
mecA genes.  Plus (+) signs represent positive 
amplification, and minus (–) signs represent no 
amplification.  Two replicates were amplified for 
each DNA sample (ATCC = American Type Culture 
Collection). 
Microorganism 
QPCR Results 
PVL gene mecA gene 
QC Organism 
 Escherichia 
coli ATCC 25922 
– – 
 Staphylococcus 
aureus ATCC 25923 
+ – 
 S. aureus 
ATCC 43300a 
– + 
 S. epidermidis 
ATCC 12228 
– – 
Specimen Id. # 
 0085 + + 
 0086 + + 
 0111 – + 
 0124 – + 
 0141 – + 
 0143 – + 
 0185 + + 
 0203 + + 
 0204 + + 
 0234 + + 
 L039 + + 
 L084 + + 
 L143 + + 
 L157 + + 
 L226 – + 
a
   MRSA strain 
Discussion 
 Studies on MRSA colonization in healthy 
pediatric populations have indicated nasal carriage 
rates ranging from 0.2 to 2.5% (Cheng Immergluck et 
al., 2004; Hussain, Boyle-Vavra, & Daum, 2001; 
Kuehnert et al., 2006; Mainous III, Hueston, Everett, 
& Diaz, 2006; Nakamura et al., 2002; Shopsin et al., 
2000).  The MRSA colonization prevalence of 3.0% 
measured for children in this study lies outside this 
range and is considerably greater than the estimate of 
0.6% (1–19 year age group) obtained in a nationwide 
survey conducted in 2001–2002 (Kuehnert et al., 
2006).  Because colonization typically precedes 
infection, it is probable that the epidemic of MRSA 
infections is a result of increasing colonization rates 
in the population nationwide.  Two studies conducted 
in Nashville, Tennessee in 2001 and 2004 showed 
that the colonization rate in children had increased 
from 0.8% to 9.2% in three years (Creech II, 
Kernodle, Alsentzer, Wilson, & Edwards, 2005; 
Nakamura et al., 2002).  Although this is the first 
known survey of MRSA colonization of healthy 
Specimen 
Antimicrobial Agent 
CC E GM LZD RA SXT Va MUP 
0085 S S S S S S S S 
0086 S S S S S S S S 
0111 R R S S S S S S 
0124 R R R S S R S S 
0141 R R S S S S S S 
0143 R R S S S S S S 
0185 S R S S S S S S 
0203 S R S S S S S S 
0204 S R S S S S S S 
0234 Ra R S S S S S S 
L084 S R S S S S S S 
L143 S S S S S S S S 
L157 S R S S S S S S 
L226 Ia R S S S S S S 
L039 S S S S S S S S 
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children in Las Vegas, the results support the premise 
that MRSA colonization rates are increasing.  While 
the number of MRSA specimens was relatively 
small, the sample size was sufficiently large to 
estimate the population prevalence rate with 95% 
confidence.  However, the small number of positives 
precludes any further comparisons of questionnaire 
data other than descriptive ones.  S. aureus was 
present in 35.0% of the specimens, similar to the 
estimate of 36.9% (1–19 year age group) obtained in 
the nationwide survey (Kuehnert et al., 2006), and to 
the prevalence of 36.4% observed in Nashville 
children in 2004 (Creech II, Kernodle, Alsentzer, 
Wilson, & Edwards, 2005). 
 The presence of the mecA gene is considered an 
indicator of methicillin resistance in Staphylococcus 
aureus (Francois et al., 2003), and all of the positive 
results obtained with the selective medium, 
CHROMagar
TM
 MRSA, were confirmed by positive 
PCR results for the mecA gene.  Previous research 
has indicated that CHROMagar
TM
 MRSA has high 
specificity and sensitivity for the detection of MRSA 
(Flayhart et al., 2005; Perry et al., 2004).  The data 
obtained from this survey showed that the enrichment 
step in the culture protocol could improve the 
detection of MRSA, as 9 of the 15 MRSA isolates 
were detected by this step.  Of the 6 MRSA isolates 
detected by direct inoculation, 5 were isolated after 
24 hours of incubation and 1 was determined after 48 
hours.  Because the enrichment broth step amplifies 
those potential pathogens in numbers too low to 
recover by routine culture techniques, it is a 
procedure that individual laboratories can choose to 
perform to enhance the detection of MRSA, 
especially in low prevalence populations.  However, 
the disadvantages of the enrichment broth step are the 
increase in the time delay to the determination of a 
negative result, and increased costs.  Therefore, this 
optional procedure may be considered by 
laboratorians depending upon their individual 
circumstances. 
 MRSA infections that are acquired by persons 
who have not been recently hospitalized or have had 
a medical procedure are termed CA-MRSA 
infections.  On the basis of questionnaire data, 10 of 
the 15 isolates in this study appear to be CA-MRSA.  
Further molecular typing is needed to characterize the 
MRSA strains isolated in this study and determine 
whether they are consistent with healthcare-
associated or CA-MRSA.  The mecA gene is located 
on a mobile genetic element, SCCmec 
(staphylococcal cassette chromosome mec) 
(Katayama et al., 2003).  There are several different 
SCCmec elements that have been characterized, with 
CA-MRSA strains typically carrying the Type IV 
SCCmec element (Huang et al., 2006; Moroney, 
Heller, Arbuckle, Talavera, & Widen, 2007).  The 
PVL gene is associated with virulence and was 
initially thought to be a characteristic of CA-MRSA 
strains.  However, one study showed that the PVL 
gene was present in only 9.3% of MRSA isolates 
containing the type IV SCCmec (Francois et al., 
2004).  In this study, the PVL gene was present in all 
5 apparent healthcare-associated MRSA isolates.  
The frequency of occurrence of the PVL gene was 
high among MRSA isolates in this study (66.7%) 
compared with the nationwide survey in which 8% of 
MRSA isolates contained the gene (Kuehnert et al., 
2005), and the 22% frequency observed in another 
study (Creech II, Kernodle, Alsentzer, Wilson, & 
Edwards, 2005).  One of the limitations of this study 
was that the MRSA isolates were not fully 
characterized according to SCCmec strain types.  
However, that was not a stated objective of this initial 
survey. 
 Four of the MRSA isolates were sensitive to all 8 
antimicrobial agents tested.  Resistance to 
erythromycin was most prevalent (11 of 15), 
followed by clindamycin (5 of 15).  One isolate 
demonstrated resistance to 4 antimicrobial agents.  
These results have clinical implications for treatment 
of MRSA infections.  Physicians treating pediatric 
patients with skin and soft tissue infections should 
consider use of empiric antimicrobial agents with 
broad spectrum against MRSA until more 
susceptibility data are  available for developing 
recommendations for antimicrobial therapy.  
Additional monitoring and research are needed to 
provide a more comprehensive estimate of the 
prevalence and types of MRSA occurring in the local 
pediatric population.  Expanded surveillance utilizing 
strain typing will permit tracking of MRSA isolates 
in community acquired and nosocomial infections.  
This will provide information that can be used to 
minimize transmission and reduce the incidence of 
MRSA in children in Las Vegas.   
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